Patients suffering trunnionosis or another hip implant failure with a Stryker LFIT Anatomic femoral head or a similar hip replacement product should call the attorneys of McEldrew Young at 1-800-590-4116 for a free, initial legal consultation. This component was used with Stryker Accolade TMZF, Accolade 2, Meridian and Citation hip implant products up to and including 2011.
Our trial attorneys have fought for victims of defective drugs and medical devices, drug-resistant infectious diseases and medical malpractice. Let us assess your legal options and put our attorneys to work fighting for you!
The Philadelphia Trunnionosis Study
A study in the Journal of Bone and Joint Surgery has identified five cases of catastrophic trunnion dissociation in Stryker Accolade TMZ Femoral Hip Stems. In a small percentage of patients with certain risk factors, the hip implant device may fail painfully approximately 7 to 7.5 years after surgery.
The Accolade TMZ Femoral Hips at issue in the study were available for use from 2001 to 2011. In the patients experiencing failure, the adverse event was clustered around 7 to 7.5 years after surgery. It is believed that severe corrosion led to the dissociation of the femoral head from the trunnion. In addition to the five patients identified, the journal article mentions two previously known cases of catastrophic trunnion dissociation in total hip arthroplasty.
The typical patient who might suffer this problem after modular total hip arthroplasty is male, taller than 5 ft 10 inch and weighing greater than 180 pounds. It is estimated that this demographic puts greater load on the femoral head-trunnion interface. The patient group explored had cobalt-chromium alloy femoral heads combined with a titanium trunnion.
The Australia LFIT Alert
Australia has issued a hazard alert for certain femoral heads used in hip replacement surgeries. Specifically, a range of LFIT Anatomic CoCR V40 femoral heads manufactured by Stryker before 2011. Australia, in consultation with Stryker Orthopaedics, expressed concerns about a higher than expected incidence of taper lock failures (another name for trunnionosis).
The taper lock connects the femoral head to the femoral neck. If it fails, a patient can experience broken bones, joint instability, pain, inflammation, loss of mobility, leg length discrepancy and the need for revision surgery.
The impacted component was used in the Stryker Accolade TMZF, Accolade 2, Meridian and Citation hip implants. The Australian alert urged orthopedic surgeons to monitor patients with the component at issue for fractured hip stem trunnion, increased metallic debris, bone fixation strength, and disassociation of the femoral head from the hip stem.
Some legal commentary in the United States is already suggesting that a recall by Stryker is imminent. Stryker has already recalled other lines of its metal-on-metal hip implants due to complaints of inflammation, metal poisoning, inflammation and organ damage. Stryker is expected to pay out more than $1 billion total to plaintiffs in the previous litigation.
About McEldrew Young
Our trial attorneys are ready to litigate on your behalf. They have handled thousands of oral arguments, mediations, arbitrations and jury trials. James J. McEldrew, III is a Past President of the Philadelphia Trial Lawyers Association. He has an extensive set of contacts with local and national physicians in order to have your medical file expertly reviewed to determine whether your injuries are the result of a product defect in the medical device.
Against Big Business
Our lawyers have sued some of the largest health care companies, insurance companies, and medical device companies both in the local area and nationally. We may be a small team but we carefully select cases so that we have the resources to litigate them properly and we are not allocating our time to a case that we don’t think we have a shot of winning.
For Individuals & Families
We represent our personal injury clients on a contingency fee basis. This means that there is no upfront cost to hire us and you owe nothing to us unless we receive a recovery for you. We know that litigation is expensive and our clients generally don’t have the money to front the cost to take a case to trial.